1 |
郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
|
2 |
Monk BJ, Tewari KS. Evidence-based therapy for recurrent cervical cancer[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2014, 32(25): 2687-2690.
|
3 |
江萍,张福泉,程光惠,等.复发宫颈癌近距离治疗专家共识[J].中华放射肿瘤学杂志,2020,29(9):721-729.
|
4 |
彭莛婷.复发性宫颈癌治疗策略研究进展[J].现代医药卫生,2020,36(21):3446-3450.
|
5 |
Abu-Rustum NR, Yashar CM, Bean S, et al. NCCN guidelines insights: cervical cancer, version 1.2020[J]. J Natl Compr Canc Netw, 2020, 18(6): 660-666.
|
6 |
Nakayama K, Teshima H, Hirai Y, et al. Stump recurrence after radical hysterectomy for patients with uterine cervical cancer (in Japanese) [J]. Nihon Sanka Fujinka Gakkai Zasshi, 1990, 42(3): 241-245.
|
7 |
Kozai Y, Itoh Y, Kawamura M, et al. High-dose-rate intracavitary brachytherapy for recurrent cervical cancer in the vaginal stump after hysterectomy[J]. Nagoya J Med Sci, 2019, 81(3): 351-358.
|
8 |
Mabuchi S, Takahashi R, Isohashi F, et al. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience [J] . Int J Gynecol Cancer, 2014, 24(1): 141-148.
|
9 |
Panici PB, Manci N, Bellati F, et al. Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence[J]. Int J Gynecol Cancer, 2009, 19(9): 1625-1631.
|
10 |
Brader KR, Morris M, Levenback C, et al. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design[J]. J Clin Oncol, 1998, 16(5): 1879-1884.
|
11 |
Tewari KS, Sill MW, Long HJ, et al. Improved survival with bevacizumab in advanced cervical cancer[J]. N Engl J Med, 2014, 370(8): 734-743.
|
12 |
Berek JS, Howe C, Lagasse LD, et al. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA[J]. Gynecol Oncol, 2005, 99(1): 153-159.
|
13 |
Abe A, Matoda M, Okamoto S, et al. Resection of the vaginal vault for vaginal recurrence of cervical cancer after hysterectomy and brachytherapy[J]. World J Surg Oncol, 2015. DOI:
10.1186/s12957-015-0495-8
|
14 |
颜士杰,陈炎.妇科内镜并发症的防治[J/CD].中华腔镜外科杂志(电子版),2016,9(2):77-79.
|
15 |
Liu J, Kohn J, Sun B, et al. Transvaginal Natural Orifice Transluminal Endoscopic Surgery Sacrocolpopexy: Tips and Tricks[J].J Minim Invasive Gynecol, 2019, 26(1): 38-39.
|
16 |
胡海,徐安安. "以史为鉴"——倡导当前胆囊结石个体化治疗策略[J/CD].中华腔镜外科杂志(电子版),2020,13(1):14-19.
|